About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On November 13, PhRMA participated in Milken Institute’s Future of Health Summit, where Executive Vice President of Policy and Research, Elizabeth Carpenter, spoke on the panel “Unlocking the Policy Agenda for the NextGen Biomedical Innovation.” During the session, Elizabeth advocated policy reform that preserves the U.S.’ world-leading innovation ecosystem and lower costs for patients as the nation prepares for the next administration and Congress.
When:
Wednesday, November 13, at 4:30 PM ET
Speakers:
- Jeff Allen, President and CEO, Friends of Cancer Research
- Elizabeth Carpenter, EVP, Policy and Research, PhRMA
- Ceci Connolly, President and CEO, Alliance of Community Health Plans
- Dora Hughes, CMO and Director, Center for Clinical Standards and Quality (CCSQ), CMS
- Peter Marks, Director, Center for Biologics Evaluation and Research, FDA
- Rick Berke, Co-Founder, Executive Editor, STAT (Moderator)
Credit to Milken Institute for photo.